7-95409919-T-C
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_000305.3(PON2):āc.677A>Gā(p.Asn226Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000636 in 1,613,402 control chromosomes in the GnomAD database, including 17 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_000305.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PON2 | NM_000305.3 | c.677A>G | p.Asn226Ser | missense_variant | 6/9 | ENST00000222572.8 | NP_000296.2 | |
LOC107986822 | XR_007060439.1 | n.558-8397T>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PON2 | ENST00000222572.8 | c.677A>G | p.Asn226Ser | missense_variant | 6/9 | 1 | NM_000305.3 | ENSP00000222572 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000329 AC: 50AN: 152154Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00119 AC: 298AN: 251168Hom.: 4 AF XY: 0.00161 AC XY: 219AN XY: 135740
GnomAD4 exome AF: 0.000668 AC: 976AN: 1461130Hom.: 17 Cov.: 31 AF XY: 0.000959 AC XY: 697AN XY: 726894
GnomAD4 genome AF: 0.000328 AC: 50AN: 152272Hom.: 0 Cov.: 32 AF XY: 0.000403 AC XY: 30AN XY: 74458
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 15, 2020 | Variant summary: PON2 c.677A>G (p.Asn226Ser) results in a conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0012 in 251168 control chromosomes, predominantly at a frequency of 0.0082 within the South Asian subpopulation in the gnomAD database, including 4 homozygotes. The observed variant frequency within South Asian control individuals in the gnomAD database is approximately 410 fold of the estimated maximal expected allele frequency for a pathogenic variant in PON2 causing Early Onset Coronary Artery Disease phenotype (2e-05), strongly suggesting that the variant is a benign polymorphism found primarily in populations of South Asian origin. c.677A>G has been reported in the literature in individuals affected with Amyotrophic Lateral Sclerosis (AML). This report however, does not provide unequivocal conclusions about association of the variant with Early Onset Coronary Artery Disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely benign. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at